Zypitamag
Payments companies reported to CMS as associated with Zypitamag. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zypitamag, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zypitamag
These are the largest totals companies reported as associated with Zypitamag. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Zaid Jabbar | Oak Brook, IL | Internal Medicine | $10,000.00 |
| Xu He | Redlands, CA | Internal Medicine | $9,652.26 |
| Maha Zikra | Orlando, FL | Endocrinology, Diabetes & Metabolism | $7,626.57 |
| Gregory Pokrywka | Towson, MD | Internal Medicine | $6,758.23 |
| Alan Brown | Naperville, IL | Cardiovascular Disease | $5,220.64 |
| John Isaac | Houston, TX | Interventional Cardiology | $5,000.00 |
| Thomas Barringer | Charlotte, NC | Family Medicine | $5,000.00 |
| Glenn Davison | Chesterfield, MO | Cardiovascular Disease | $4,199.89 |
| Nathaniel Lebowitz | Fort Lee, NJ | Cardiovascular Disease | $3,850.00 |
| Susan Dimick | Edmond, OK | Family Medicine | $1,622.34 |
Prescribed Zypitamag?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.